Abstract: The management of chronic conditions is characterized by frequent re-assessment of therapy decisions in response to the patient's changing condition over the course of the illness. Evidence most suitable to inform care thus often concerns the contrast of adaptive treatment strategies that repeatedly personalize treatment decisions over time using the latest accumulated data available from the patient's previous clinic visits such as laboratory exams (e.g., hemoglobin A1c measurements in diabetes care). The frequency at which such information is monitored implicitly defines the causal estimand that is typically evaluated in an observational or randomized study of such adaptive treatment strategies. Analytic control of monitoring with standard estimation approaches for time-varying interventions can therefore not only improve study generalizibility but also inform the optimal timing of clinical surveillance. Valid inference with these estimators requires the upholding of a positivity assumption that can hinder their applicability. To potentially weaken this requirement for monitoring control, we introduce identifiability results that will facilitate the derivation of alternate estimators of effects defined by general joint treatment and monitoring interventions in the context of time-to-event outcomes. These results are developed based on the nonparametric structural equation modeling framework using a no direct effect assumption originally introduced in a prior paper that inspired this work. The relevance and scope of the results presented here are illustrated with examples in diabetes comparative effectiveness research.
Introduction
Effective management of chronic conditions such as diabetes involves frequent re-evaluation of treatment decisions over the course of the patient's illness. Patients and their clinicians must choose not only adequate therapies among many options, but they must also decide throughout the course of the illness when to initiate, switch or intensify treatments and how to titrate medication to balance health benefits and harms. These clinical decisions are informed by periodic monitoring of laboratory test results (e.g., hemoglobin A1c for patients with diabetes), changes in symptoms, and more general considerations of patients' preferences, concurrent conditions, adherence to previously prescribed treatments, and overall health. Evidence most suitable to guide the real-world management of chronic conditions must therefore involve the evaluation of complex treatment strategies that continuously adapt to new information about the patient's changing circumstances collected during routine clinic visits. For instance, in diabetes research, contrasting (e.g., by randomization) adaptive treatment regimens of the type:
will generate evidence that is clinically more relevant that contrasting static treatment regimens of the type "Initiate insulin X months from now" with X =3, 6, 9, or 12 because the former regimens emulate (albeit simplistically) how treatment decisions are made in real-world clinical practice by personalizing treatment decisions over time based on the latest A1c information available for the patient. With the help of healthcare providers, the above adaptive treatment regimens can be made more complex so they better emulate how treatment decisions are informed in real-world clinical settings and thus ensure that the evidence generated is most useful by contrasting decision making procedures that are (or could be realistically) used by clinicians in practice.
Causal inference methods to estimate the effects of treatment regimens in the presence of timedependent confounding have been developed specifically to generate such evidence using data from observational studies [1, 2, 3, 4, 5, 6] or randomized experiments [7, 8, 9, 10, 11 12] . Until recently [13, 14] however, applications have ignored the role of clinical monitoring frequency in the definition of the effects of adaptive treatment strategies. As a result, conclusions about health benefits and harms remain specific [4, Section 6 ] to the particular clinical monitoring conditions of the study which may or not reflect a particular real-world practice of interest. For example, two perfect randomized trials (no non-compliance and no loss to follow-up) that are conducted in the same patient population but using two distinct clinical monitoring schedules could provide different conclusions (both valid) about the effectiveness of an adaptive treatment strategy compared to the same, for example, static (i.e., non-adaptive) treatment strategy (e.g., never treat).
Evaluating the joint effect of an adaptive treatment strategy and a particular clinical monitoring intervention is thus desirable to, not only, improve the generalizibility [4, 15, 16] of study results, but also, more importantly, to generate evidence on how clinical monitoring modify the health effects of adaptive treatment strategies. For instance, in diabetes research, contrasting joint treatment and monitoring regimens of the type:
"Monitor the patient's A1c every X months and initiate insulin the first time her A1c drifts above 8%" with X = 3, 6, 9, 12 can generate evidence about the value of increased A1c monitoring ("value of information" [4] ) that can be highly relevant for both patients living with chronic conditions and for the health systems that care for them: A patient's quality of life is impacted by the burdens imposed by frequent laboratory and other clinical surveillance and this surveillance also contributes to the significant burdens that chronic conditions put on healthcare systems. Thus, not only is evidence on how to possibly minimize the intensity of clinical monitoring without significantly undermining health outcomes relevant to inform care, but also evidence that aim to optimize outcomes by adapting monitoring decisions over time based on a patient's evolving condition. The latter type of evidence can, for example, be generated by contrasting joint treatment and monitoring regimens of the type:
"Monitor the patient's A1c every X months as long as her latest A1c remain below 7% and increase monitoring to every 3 months otherwise. Initiate insulin the first time her A1c drifts above 8%" with X = 3, 6, 9, 12.
Standard estimation approaches for evaluating the effect of general time-varying exposures with observational data can be readily applied to the evaluation of the joint effect of an adaptive treatment strategy and a particular clinical monitoring intervention by simply defining the exposure variable of interest at each time point as a two-dimensional variable where the first and second element represents the treatment and monitoring decision, respectively. These methods include not only the most popular Inverse Probability Weighting (IPW) [17] and G-computation [18] estimation approaches but also the two doubly robust and locally efficient augmented-IPW [19, 20, 21, 22, 23] and Targeted Minimum Loss based Estimation (TMLE) [24, 25, 26] approaches. Effect identifiability with these various estimators relies on both a no unmeasured confounders assumption and a positivity assumption. The latter assumption requires that each patient in the study can possibly experience the time-varying interventions of interest at each time point whatever the levels of the time-dependent confounders. Upholding of this assumption when the timevarying interventions include rigid monitoring control (e.g., "patient should have her A1c monitored exactly every 3 months") might often be unrealistic in observational studies conducted in real-world settings. Concerns over effect non-identifiability due to violation of the positivity assumption associated with monitoring decisions have motivated prior work [4, Section 6] and led to the development of new IPW estimators which remain consistent under a weaker positivity assumption for monitoring decisions as long as it can also be assumed that these monitoring decisions have no direct effects on covariates (including the outcome) once treatment decisions are made. This assumption was named the No Direct Effect (NDE) assumption and the resulting NDE-based IPW estimators were developed in problems with an end-of-study outcome and for static or more general (adaptive or not) stochastic monitoring interventions.
In this article, we extend this prior work in the context of time-to-event outcomes with the presentation of two counterfactual identifiability results. These two counterfactual equalities are developed based on the nonparametric structural equation model (NPSEM) framework [27, 28, 29, 30] and applicable to the evaluation of the joint effect of an adaptive treatment strategy and either a static or general stochastic clinical monitoring intervention under the NDE assumption. The practical implication of the results presented here is the straightforward derivation of new IPW, G-computation, augmented IPW and TMLE estimators that rely on a weaker positivity assumption for the monitoring process compared to their standard analogs (i.e., not based on the NDE assumption). We note, however, that while we illustrate the implication of the results in this paper for estimator construction using the IPW methodology with the simple example of static monitoring interventions, the detailed derivation and evaluation of alternate estimators and of the required assumptions for estimation consistency (e.g., sequential randomization assumption) are beyond the scope of this article. In separate work, we will further exploit the two identifiability results presented here to demonstrate that they lead, not only, to another innovative NDE-based IPW estimator for general stochastic monitoring interventions derived in a prior paper [4] (without formally evoking the results of this article), but also to the straightforward derivation of NDE-based TMLE estimators for either static or general stochastic monitoring interventions.
In the next section, we present the notation adopted in this paper to represent the general longitudinal observational data available in practice to evaluate the joint treatment and monitoring effects of interest. In Section 3, we introduce the causal model defined by a general NPSEM that is assumed to have generated the observed data and that defines the various classes of counterfactual variables considered in this work. We detail the definition of these counterfactuals in Section 4 before formalizing the NDE assumption. In Sections 6 and 7, we present the two identifiability results for evaluating joint effects defined by static and general stochastic monitoring interventions, respectively. We illustrate the practical implication of these results for estimator construction in Section 8 and conclude with a discussion of the contribution of this paper to the existing literature on the same topic in Section 9. For clarity, we continue to use examples in diabetes comparative effectiveness research (CER) throughout the manuscript to demonstrate the applicability of the formalism introduced in the next sections.
Observed data
We consider an observational study (e.g., retrospective study based on Electronic Health Records from a healthcare database) in which longitudinal data are collected on a random sample of n patients from a target population starting at the index date (i.e., cohort entry date denoted by t = 0) and until end of follow-up defined by the earliest occurrence of a failure event of interest (e.g., onset of diabetic peripheral neuropathy) or a right-censoring event (e.g., health plan disenrollment). Right-censoring events include reaching the administrative end of the study which occurs for all patients at time t = K + 1 at the latest. At each time point t during follow-up (expressed in an arbitrary unit of time, e.g., 30-day interval), measurements on the following variables are assembled. The sequence in which we describe these variables reflects the actual temporal ordering of the underlying information these variables encode. The binary outcome variable YðtÞ represents whether the failure event occurred since time point t − 1 (Yð0Þ = 0 by convention). The vector of covariates ZðtÞ represents various patient attributes (e.g., demographic, vital signs, comorbidities, etc.) at time t. We note that some of these attributes may not be monitored at each time point in which case indicators of monitoring are included as part of the definition of ZðtÞ and the unmonitored attribute measurements are then equal to 0 by convention. The covariate IðtÞ represents the patient's attribute at time t (e.g., A1c) that is involved in the definition of the adaptive treatment regimen of interest and for which a monitoring intervention is also of interest. By convention, Ið0Þ is always monitored and IðtÞ ≡ 0 if the attribute is not monitored at time t. The binary variable A 2 ðtÞ represents whether the patient experiences a right-censoring event at time t. The variable A 1 ðtÞ represents the treatment decision of interest at time t (e.g., insulin exposure). The binary variable NðtÞ represents the monitoring decision of interest at time t and indicates whether a measurement for Iðt + 1Þ will be collected (e.g., whether an A1c test will be conducted at the next time point). We thus have Iðt + 1Þ = 0 if NðtÞ = 0. In short, the observed data are realizations of n independent and identically distributed copies of the following temporally ordered sequence of random variables: where LðtÞ ≡ ðYðtÞ, ZðtÞ, IðtÞÞ, A 2 ðK + 1Þ = 1 if YðK + 1Þ = 0 (i.e., right-censoring from reaching the administrative end of the study is deterministic at K + 1), and where, by convention, all variables become degenerate (defined at their last observed value) after occurrence of a failure or right-censoring event. Timeindependent covariates (e.g., sex) are included in the vector of baseline covariates Lð0Þ alongside the baseline measurements of time-varying covariates. We denote the distribution of these observed data O by P 0 . To simplify notation below, we use the overbar symbol to denote the history of a variable. 
Causal model
We assume the following nonparametric structural equation model (NPSEM) that links (Appendix A) the observed data distribution P 0 to the probability distribution (denoted by P U ) of a vector of random disturbances U ≡ À In this NPSEM, the observed covariate IðtÞ is explicitly linked to a latent variable I 0 ðtÞ which represents the patient's underlying attribute measurement of interest at time t. More specifically, as long as the patient has not experienced failure yet, if a decision was made not to collect the measurement I 0 ðtÞ at the previous time point (i.e., when Nðt − 1Þ = 0) then IðtÞ = 0 (which follows the convention described in the previous section to define IðtÞ) and otherwise IðtÞ = I 0 ðtÞ (i.e., when Nðt − 1Þ = 1).
The combination of the latent variable I 0 ðtÞ and observed variables YðtÞ, ZðtÞ, A 2 ðtÞ, A 1 ðtÞ, and NðtÞ are referred to as endogenous variables 1 and we note that the previous constraints on the functions f merely encode 1) the convention that the baseline outcome is 0, 2) the convention that the endogenous variables are defined as degenerate random variables after end of follow-up from occurrence of a failure or rightcensoring event, and 3) deterministic right-censoring from administrative end of study at t = K + 1.
We note also that the definition of the observed measurement IðtÞ above implies that, like all other endogenous variables, it becomes degenerate at its last observed value after the occurrence of, not only, the failure event, but also a right-censoring event, i.e., IðtÞ = Iðt − 1Þ if YðtÞ = 1 or A 2 ðt − 1Þ = 1.
Finally, we introduce the notation L 0 ðtÞ ≡ ðYðtÞ, ZðtÞ, I 0 ðtÞÞ for t = 0, . . . , K + 1 and bring attention to the distinction between L 0 ðtÞ and the observed vector of covariates LðtÞ = ðYðtÞ, ZðtÞ, IðtÞÞ.
Counterfactual variables of interest
Whether conducted with a randomized experiment or an observational study, CER typically aims to evaluate causal estimands defined by the distribution of "potential outcomes", i.e., outcomes if all patients in the target population experienced the "same" (possibly adaptive or stochastic) exposure intervention. In this section, we differentiate five classes of general counterfactual variables considered in this work. Each is defined by a particular modification of the previous NPSEM as described below.
The NPSEM is modified by changing the structural equations associated with a set (denoted by x) of endogenous variables referred to as the action variables. More specifically, for each action variable XðtÞ 2 x, the original structural equation XðtÞ = f XðtÞ ðP 
Static intervention on the treatment and right-censoring variables
In this section, we formalize the definition of counterfactual outcomes involved in the evaluation of the following types of CER question in a cohort of diabetes patients whose glycemia has become out of control (e.g., A1c ≥ 7%) despite prior therapies with oral agents (e.g., metformin therapy): What is the difference in the risk of onset diabetic peripheral neuropathy (DPN) if patients initiate insulin therapy at study entry versus delay initiation by 12 months? We note that such risk evaluation would require that all patients remain followed-up for the entire duration of the study (i.e., no loss to follow-up). Because the treatment interventions of interest in the example above are not adapted to the patient's covariates, the treatment interventions are referred to as static. We denote such static intervention regimens on the treatment and right-censoring variables through time K by a * ≡ ð a 
Static intervention on the treatment, right-censoring, and monitoring variables
The static treatment and right-censoring interventions defined in the previous section are now supplemented by a static intervention on the monitoring process. We denote any given static intervention regimen of interest on monitoring through time K by n * ≡ n * ðKÞ. 4.4 Static intervention on the right-censoring variables combined with a stochastic intervention on the monitoring variables and a dynamic intervention on the treatment variables
In this section, we consider a general class of monitoring interventions which can be used to address four types of CER questions that are each illustrated below before formalizing the definition of these interventions with a unifying notation. So far, the static monitoring intervention considered required that patients adhere to a rigid A1c testing schedule with no tolerance for even slight deviations (i.e., advanced or delayed monitoring). Here, we consider more realistic monitoring interventions that can reflect real-world adherence to monitoring guidelines. More specifically, we formalize the definition of counterfactual outcomes involved in the evaluation of the following types of diabetes CER questions: (Q1) What is the difference in the risk of onset DPN if patients' A1c are monitored on average every 3 versus 6 months and patients initiate insulin therapy the first time their A1c drifts above 8.5%? The monitoring interventions of interest are now stochastic. In addition, we also consider here adaptive (deterministic or stochastic) monitoring interventions which allow the personalization of monitoring decisions over time based on the patient's latest observed condition. More specifically, we also formalize below the definition of counterfactual outcomes involved in the evaluation of the following types of diabetes CER questions: (Q2) What is the difference in the risk of onset DPN if patients initiate insulin therapy the first time their A1c drifts above 8.5% and their A1c is monitored on average every 3 versus 6 months as long as their latest A1c remain below 7% and on average every 3 months otherwise?
The monitoring intervention of interest is now, not only, stochastic, but also adaptive. We note that, to formally evaluate the effects of interest in the previous two examples, the analyst must first define the monitoring interventions of interest more precisely by specifying monitoring distributions that would result in patients having on average their A1c collected every 3 or 6 months (possibly conditional on the last observed A1c value). Many such distributions can be chosen and each would lead to a different effect measure. While real-world adherence to the stochastic interventions above is more realistic than adherence to the static intervention described in the previous sections, they do not accommodate for the occurrence of unexpected events (e.g., severe hypoglycemia) which would require additional monitoring in practice. To avoid arbitrary specification of monitoring distributions and to further increase the relevance of the evidence generated to real-world settings, we also consider here alternate monitoring interventions which require that gaps between two A1c test not exceed a given threshold. More specifically, we also formalize here the definition of counterfactual outcomes involved in the evaluation of the following types of diabetes CER questions: (Q3) What is the difference in the risk of onset DPN if A1c monitoring precludes gaps between measurements greater than 6 versus 12 months and patients initiate insulin therapy the first time their A1c drifts above 8.5%? The monitoring interventions of interest are now restricted to only enforcing monitoring as soon as the patient's last A1c measurement is 6-month (or 12-month) old and A1c monitoring is not intervened upon in between such monitoring interventions (i.e., monitoring follows the natural decision process of the setting in which the study is conducted). Finally, we also consider here monitoring interventions that are defined by uniformly increasing or decreasing the probability of A1c monitoring at each time point defined by the natural decision process of the study. More specifically, we also formalize here the definition of counterfactual outcomes involved in the evaluation of the following types of diabetes CER questions: (Q4) What is the difference in the risk of onset DPN if at each time point 10% versus 20% of patients who would otherwise not be monitored had their A1c tested and all patients initiate insulin therapy the first time their A1c drifts above 8.5%?
The effect of any one of the intervention regimens described above on all other endogenous variables in the causal model is defined by the modified NPSEM with the following structural equations for the action We now illustrate how particular choices for the function h 
Static intervention on the right-censoring variables and a subset of the monitoring variables combined with a dynamic intervention on the treatment variables
In this section, we formalize the definition of counterfactual variables involved in the two identifiability results presented later in this paper. They are defined by the interventions introduced in Section 4.3 with the difference that the interventions on the monitoring variables NðtÞ are now restricted to the subset of monitoring variables identified by the time points t when the static monitoring interventions n * ðtÞ are equal to 1.
Neugebauer et al: Identification of joint effects under the NDE assumption
The effect of such an intervention regimen on all other endogenous variables in the causal model is defined by the modified NPSEM with the following structural equations for the action variables for any given distribution P U * jU and a particular choice of dynamic treatment intervention d * x ðtÞ :P A * 1 ðtÞ 7 !a * 1 ðtÞ for t = 0, . . . , K. We note that the conditional probability (denoted by g * ) of the counterfactual variable N * ðtÞ above given its parents will not typically be degenerate for a general choice of static monitoring regimen n * .
By analogy with the effect definition described in the previous section, one may thus view the intervention on monitoring above as a stochastic intervention on the monitoring process NðtÞ such that the distribution of the resulting counterfactual monitoring variable N * ðtÞ is defined as degenerate at 1 for time points t when n * ðtÞ = 1 and defined by the distribution P U and functions f NðtÞ otherwise. 
ðtÞ and N d * x , g * ðtÞ, respectively. Note that here again, we omit the use of the subscript a * 2 ðKÞ and thus make the intervention on the right-censoring variables implicit in the notation of these counterfactual variables. We denote the support of the counterfactual treatment and monitoring processes
No direct effect (NDE) assumption
We denote, respectively, by a * and n * , the union of the supports of the counterfactual treatment 
We note that these sets contain the supports of, not only, the observed treatment and monitoring processes, but also the supports of the various counterfactual treatment and monitoring processes defined in Section 4 based on specific choices for a
We define the NDE assumption as the following set of equalities: for all t = 0, . . . , K, a * 1 2 a * , and
where we use the generic notation P 0 X * ðt + 1Þ, n *′ to denote the vector of variables defined by the parents P We note that the NDE assumption is implied by the assumption that the functions f YðtÞ , f ZðtÞ and f I 0 ðtÞ do not depend on the monitoring process Nðt − 1Þ for t ≥ 1. As illustrated in Figure 1 , the latter exclusion restrictions can be encoded graphically in a Directed Acyclic Graph (DAG) with the absence of arrows from a node NðtÞ to any subsequent covariate nodes YðjÞ, ZðjÞ, and I 0 ðjÞ for j > t. Such exclusion restrictions do not preclude however the existence of directed paths from a node NðtÞ to any subsequent covariate nodes YðjÞ, ZðjÞ, and I 0 ðjÞ but requires that all such paths be intercepted by treatment or censoring nodes A 2 ðjÞ or A 1 ðjÞ for j > t .
In Appendix B, we show that the NDE assumption above is equivalent to the following equalities between the counterfactuals introduced in Sections 4.1 and 4.2:
We note that this latter formulation of the NDE assumption was introduced in prior published work [4] which was not based on an NPSEM and in which counterfactuals were instead introduced as primitives [31] . We also define the weak NDE assumption (which is implied by the NDE assumption above) as the upholding of one of the following two sets of equalities defined by the same choice of interventions n * , d x , and d
, U I 0 ðt + 1Þ Þ = f I 0 ðt + 1Þ ðP
A1 (2) N(2) Figure 1 : Example of a Directed Acyclic Graph consistent with the general NPSEM introduced in Section 3. This graph assumes, in particular, that all disturbances are mutually independent, that the nodes Y ðtÞ and ZðtÞ share the same parents (with t = 1, 2), and that right-censoring is completely at random. The exclusion of the arrows represented with dashed lines in this diagram graphically encodes the upholding of the NDE assumption introduced in Section 5.
The equalities eq. (5) (resp. eq. (6)) above encode the assumption that the NPSEM functions that generate the covariates Yðt + 1Þ, Zðt + 1Þ, and I 0 ðt + 1Þ for t = 0, . . . , K return the same values whether their input arguments are set to the vector of their respective counterfactual parents under the interventions from Section 4.5 (resp. Section 4.3) or set to the same vector in which the counterfactual monitoring history N d * x , g * ðtÞ (resp. N dx, n * ðtÞ) is replaced with the counterfactual monitoring history N dx, n * ðtÞ from Section 4.3 (resp. N d * x , g * ðtÞ from Section 4.5).
6 Identifiability result 1
In Appendix C, we prove the following equalities of counterfactuals.
Theorem 1 For any given dynamic treatment intervention d x defined in Section 4.3 and any given static monitoring intervention n * , if the dynamic treatment intervention d * x is defined as the dynamic treatment intervention d x applied using only the information from the past covariate process IðtÞ available under both the actual observed monitoring process and the static monitoring regimen n * , i.e., for t = 0, . . . , K:
with the function Γ n * :P A1ðtÞ 7 !P n 
and the following counterfactual equalities also hold:
where we recall (see Section 4.5 for details) that the stochastic intervention g * on the monitoring process is entirely defined by a static intervention on a subset of the monitoring variables before failure (setting them to 1 whenever n * ðtÞ = 1 while all other monitoring variables are not intervened upon).
Identifiability result 2
In Appendix D, we prove the following results.
Theorem 2
The following equality (13) 
where n * is defined by an arbitrary choice for n * ðt, KÞ, IðÁÞ denotes the indicator function, and the functions g are defined by the distribution of the counterfactual variables introduced in Section 4.4 as follows: g À nðjÞ j p nðjÞ Á = P N dx, g ðjÞ = nðjÞ j P N dx , g ðjÞ = p nðjÞ
when the conditional probabilities on the right-hand side are well-defined (i.e., the conditional event has nonzero probability) and otherwise (e.g., when a 2 ðjÞ 6 ¼ 0), by convention, g À nðjÞ j p nðjÞ Á = P U, U * ðU NðjÞ , U 
and the functions f NðtÞ are not dependent on the latent variables I 0 ðtÞ for t = 0, . . . , K:
f NðtÞ ðP 0 NðtÞ , U NðtÞ Þ = f ′ NðtÞ P NðtÞ , U NðtÞ (15) for a function f ′ NðtÞ of only the observed parents P NðtÞ and U NðtÞ . In addition, if both the previous equality (13) and the (weak) NDE assumption hold then the following equality also holds:
where we use the definition for the interventions d * x and g * given in Theorem 1,
. Equality (16) corresponds to equality (13) with the difference that all counterfactual variables resulting from the joint treatment and monitoring interventions d x and n * on the right-hand side of equality (13) are replaced with counterfactual variables resulting from the joint treatment and monitoring interventions d
and g * (using the counterfactual equalities from Theorem 1).
We note that while the conditional independence assumptions (11) and condition (12) only put constraints on the definition of intervention regimens (specified by the analyst) for which equalities (13) and (16) can hold, the conditional independences (14) and exclusion restriction (15) can be viewed instead as causal assumptions since they restrict the class of NPSEM (not under the analyst's control) for which these equalities can hold.
In practice and as illustrated with the four monitoring intervention types (Q1-Q4) described in Section 4.4, the conditional independence assumptions (11) will typically hold since interventions that have been commonly considered in real-data analyses can be defined using disturbances U * (specified by the analyst)
that are independent of each other and of all disturbances U. However, condition (12) precludes stochastic monitoring interventions that are defined based on the monitoring decisions (N *0 ðtÞ) that would naturally occur under no monitoring interventions such as two of the four types of interventions illustrated in Section 4.4, more specifically, the interventions involved in the CER questions (Q3) and (Q4). In particular, this assumption also excludes monitoring interventions of the type "intention-to-treat" where monitoring variables are only intervened upon up to occurrence of some events (e.g., start of treatment). The conditional independences (14) holds in practice if it can be assumed that all backdoor paths from any given monitoring node NðtÞ to all subsequent covariates including the latent variables I 0 ðjÞ are blocked by conditioning on past treatment, right-censoring, monitoring and covariates (including the past latent variables I 0 ðjÞ). The exclusion restriction (15) corresponds with the assumption of no arrows from any node I 0 ðjÞ to any subsequent monitoring node NðkÞ for k ≥ j in a DAG (past latent covariates can have however an indirect effect on monitoring through past observed covariates).
Practical relevance
Although the exploitation of the two identifiability results in this article to derive alternate NDE-based estimators of the joint effect of a dynamic treatment intervention and a general monitoring intervention will be detailed in separate work, we briefly illustrate below the practical implications of the formal results presented above with a simple example introduced in Section 4.3.
To address the diabetes CER question "What is the difference in the risk of onset DPN if patients have their A1c monitored every 3 months versus every 6 months and initiate insulin therapy the first time their A1c drifts above 8.5%?", we would aim to evaluate the following causal estimands for t = 0, . . . , K: where the notation g 0 in the denominator refers to the conditional probabilities (defined by P 0 ) of each action variable given the subset of its observed parents and the notation TðtÞ represents the minimum of time t and the patient's follow-up time, i.e., TðtÞ = min ðt, T, CÞ, with T denoting the failure time when it occurs, i.e., T ≡ min fj = 0, . . . , K :Yðj + 1Þ = 1g and is nil if
YðK + 1Þ = 0, and C denoting the right-censoring time when it occurs, i.e., C ≡ min fj = 0, . . . , K :A 2 ðjÞ = 1g and is nil if A 2 ðK + 1Þ = 0. Thus, the following solution of the estimating equation associated with this estimating function defines a consistent and asymptotically linear estimator [19] 
and where the subscript i is used to identify each of the n independent and identically distributed copies of the observed data process O (or, by extension, any components of O) defined in Section 2. If the NDE assumption holds, we can also make use of the equality EðY d x , n * ðt + 1ÞÞ = EðY d * x , g * ðt + 1ÞÞ implied by Theorem 1 to indirectly develop another IPW estimator of ψ d x , n * through the evaluation of the causal estimand ψ d * x , g * ≡ EðY d * x , g * ðt + 1ÞÞ using the same general IPW estimation methodology just described but applied now to the joint dynamic treatment and stochastic monitoring intervention ðd * x , g * Þ instead of the joint dynamic treatment and static monitoring intervention ðd x , n * Þ. We recall that the stochastic monitoring intervention g * consists of a static intervention on a subset of the monitoring variables before failure (setting them to 1 whenever n * ðtÞ = 1 while all other monitoring variables are not intervened upon).
More specifically at each time point t, each of the counterfactual cumulative risks ψ d * x , g * with n * = n 
where we use bold font to highlight the difference with the IP weights (18) (17, 18) but, unlike that latter estimator, it relies on a possibly weaker positivity assumption which can translate into improved estimation properties as discussed further below. Another important practical consequence of the identifiability results in this paper is the simplification of the development of NDE-based doubly robust and locally efficient estimators of the effect of joint dynamic treatment and general monitoring interventions. The description of these new estimators is left for future work.
As just noted, consistent estimation of the causal estimand ψ dx, n * with either the standard bounded IPW estimatorψ , i.e., be monitored every 6 months with no additional monitoring in between these monitoring events, whereas the second positivity assumption only requires that each subject can possibly be monitored every 6 months and does not place any constraint on the monitoring decision processes in between these 6-month periodic monitoring events. Thus, as highlighted by the bold font, a quick examination of these two assumptions suggest that the second positivity assumption is weaker than the first because the constraints of strictly positive monitoring probabilities will generally apply to a smaller set of monitoring variables for the intervention g * than for the intervention n * . The expected practical consequence of this weakening of the positivity assumption for monitoring decisions is improved estimation performance (bias and precision) for the NDE-based IPW estimatorψ bd ipw d *
x , g * compared to that of the standard estimatorψ bd ipw dx, n * because of the likely more stable IPW weights (19) that result from the exclusion of the terms Q j ≤ T i ðtÞ :n * ðjÞ = 0 g 0 ðN i ðjÞ j P NðjÞ, i Þ from the definition of the denominators of the NDE-based IP weights compared to that of the standard IP weights (18) . A closer examination of the positivity assumptions above suggests however that, in practice, gains from weakening of the positivity assumption for the monitoring process might be offset by the fact that there might be fewer observations whose treatment history is concordant with following the dynamic intervention d * x or the fact that, for these observations, the treatment factors Q T i ðtÞ j = 0 g 0 ðA 1, i ðjÞ j P ′ A 1 ðjÞ Þ might be closer to 0 than for the observations whose treatment history is concordant with following the dynamic intervention d x (i.e., for the observations contributing to the standard IPW estimator (17, 18) ). Future applied work with simulated and real data should provide practical insights into the relevance of NDEbased estimators by studying the potential trade-off between improved weight stability resulting from an intervention g * on fewer monitoring variables and worsened weight stability resulting from poorer adherence to a treatment strategy d * x that requires that treatment decisions be made as if some past observed information about the patient's condition had actually been unobserved. Similarly, such applied work should also illustrate the stronger sequential randomization assumption (SRA) required for consistent estimation of the joint effect of a dynamic treatment intervention and a stochastic (e.g., static) monitoring intervention compared to the weaker SRA required for consistent estimation of the effect of a dynamic treatment intervention (without a monitoring intervention). In particular, it has been argued [4, Section 7] that the stronger SRA requirement will impede applications of these estimators in studies based on standard Electronic Health Records databases "[...] unless we collect data at t on the health status of not only those who return to the clinic at t (which we typically do) but also those who do not come to the clinic a t (which we almost never do)".
Discussion
In this article, we utilized the NPSEM framework to formally derive two identifiability results for evaluating the effect of general joint treatment and monitoring interventions on time-to-event outcomes under a no direct effect assumption. In addition, we illustrated the practical relevance of these identifiability results by showing how one of them can be directly exploited to easily derive a new NDE-based estimator by simply applying a common estimation approach. More specifically, we have shown that our first identifiability result quickly leads to the construction of a bounded IPW estimator for the counterfactual cumulative risk under a joint dynamic treatment intervention and a static monitoring intervention. We also noted that a slightly different NDE-based estimator that can similarly be derived from our first identifiability result corresponds to the unbounded (Horvitz-Thompson) IPW estimator presented in prior work. This unbounded estimator had been formally derived based on the missing data framework for problems with end-of-study outcomes using a novel theorem.
With this paper, our intention is not to emphasize that the IPW estimator developed here is novel or better because it is bounded, NPSEM-based, or applicable to time-to-event outcomes compared to the unbounded alternative developed previously for end-of-study outcomes and derived based on the missing data framework. Instead, we want to highlight how formal derivation of NDE-based estimators can be made transparent and simple using the identifiability results presented here. Indeed, our example shows that the unbounded IPW estimator developed in prior work actually corresponds to a usual (i.e., based on the standard G-computation formula from Robins [18] ) IPW estimator that targets a particular causal estimand which happens to equal the intended causal estimand of interest when the NDE assumption holds. If the NDE assumption is violated, our result also directly implies that the estimator can remain causally interpretable. This result is an additional contribution which, to our knowledge, was not formally noted previously.
In short, we propose that results in this paper can, not only, further explicate previously proposed NDEbased IPW estimators but also facilitate the derivation of alternate NDE-based estimators using existing general estimation roadmaps such as those rooted in the standard G-computation formula (e.g., maximum likelihood, IPW, augmented-IPW, and targeted minimum loss based estimators). These results also show that NDE-based estimators can remain causally interpretable even when the NDE assumption is violated. Under the causal model encoded by the NPSEM above, the distribution of the vector of disturbances u defines the distribution of the observed data O as follows:
Iði 0 ð0Þ = ið0ÞÞ 
where bold font is used to underscore the random variables and we recall that o = ð lðK + 1Þ, a 2 ðK + 1Þ, a 1 ðKÞ, nðKÞÞ with lðtÞ = ðyðtÞ, zðtÞ, iðtÞÞ and l 0 ðtÞ = ðyðtÞ, zðtÞ, i 0 ðtÞÞ for t = 0, . . . , K + 1.
B Proof of the equivalence between the NPSEM-based (3) and counterfactual-based (4) formulations of the NDE assumption
Proof that the set of equalities (3) implies the set of equalities (4):
Below, we show that the set of equalities (3) implies the following proposition for any k = 0, . . . , K, a where we also made use of equalities (23) and (24) (both just shown to be implied by equalities (A)). Because the set n * contains the support of N a * ðKÞ (by definition (2)), the set of equalities (3) implies that the right-hand side of the previous equality is equal to f I 0 ðk + 1Þ ðP where the last equality is directly derived from the definition of the counterfactual outcome I 0 
By induction, the previous two propositions imply that equalities (4) hold when equalities (3) hold.
Proof that the set of equalities (4) implies the set of equalities (3):
Below, we show that the set of equalities (4) 
Using equalities (A) and equality (26) (just shown to be itself implied by equalities (A) and (4) 
From the definition of the counterfactuals L a * , n * ð1Þ described in Section 4.2, we also have , U I0ð1Þ Þ.
Using the equality L a * ,
n * ′ ð1Þ implied by equalities (4), the previous two sets of equalities (27) and (28) imply that that the equalities Eð0Þ hold. We have just shown the proposition that equalities (A) hold at k = 0 when equalities (4) hold.
By induction, the previous two propositions imply that equalities (3) hold when equalities (4) hold.
C Proof of the first identifiability result
Below, we show that the (weak) NDE assumption (i.e., equalities (3), (5) or (6)) implies the following proposition for any t = 1, . . . , K:
where the definition of the dynamic intervention d * x is given by (7) for any given dynamic treatment intervention d x defined in Section 4.3 and any given static monitoring intervention n * and where the monitoring intervention g * is defined in Section 4.5 using the same choice for n * .
From the definition of the variables in the causal model given in Section 3, their n * -specific transformation defined by (8) , and the definition of their counterfactual analogs given in Section 4, we have
Neugebauer et al: Identification of joint effects under the NDE assumption
x , g * ðt − 1Þ, and I 0 dx , n * ðtÞ = I 0 d * x , g * ðtÞ. As a result, equality (29) becomes
ðtÞ.
By transitivity and using equality (30), we obtain
We have just shown:
From the definition of the counterfactual variables given in Sections 4.3 and 4.5, we have
If equalities (A) hold, equality (32) becomes
By transitivity and using equality (33), we obtain
We have just shown: ðAÞ )
From the definition of the dynamic interventions d * x given by expression (7), equality (36) becomes:
If equalities (A) hold, the previous equality becomes
where we also made use of equalities (31) and (34) (just shown to hold if equalities (A) hold). Using the parent notation, the previous equality can be expressed as
By transitivity and using equality (35), we obtain
From the definition of the variables in the causal model given in Section 3, their n * -specific transformation defined by expression (8) , and the definition of their counterfactual analogs given in Section 4, we have
These equalities imply: -If n * ðtÞ = 1 and x , g * ðtÞ = 0 from equality (38). If equalities (A) hold, we also have Y dx, n * ðtÞ = Y d * x , g * ðtÞ and therefore N dx, n * ðtÞ = 0 from equality (39). As a result, we also obtain
x , g * ðtÞ = 1 then we obtain from equalities (A), (38) and (39):
If equalities (A) hold then
x , g * ðt − 1Þ. By transitivity using the latter equality and equalities (41) and (42), we also obtain
By definition of the counterfactuals in Section 4.5, we have:
Because the set a * contains the support of A d * x , g * ðKÞ and because n * contains the supports of both N d * x , g * ðKÞ and N d x , n * ðKÞ (by definitions (1) and (2)), the right-hand sides of the previous equalities can be modified as follows under the NDE assumption (3):
where we use the generic notation P By transitivity, the last two equalities imply:
By expanding the parent notation and then making use of the equality just shown to hold but also equalities (A), (34) and (37), the second of equalities (43) becomes By transitivity, the last two equalities imply:
By expanding the parent notation and then making use of both equalities (44) and (45) just shown to hold but also equalities (A), (34) and (37), the third of equalities (43) becomes By transitivity, the last two equalities imply:
We have just shown that the NDE assumption (3) implies: ðAÞ )
ðt + 1Þ. We note that the proof of this result also holds under the weak NDE assumption if equalities (5) hold (because equalities (5) imply equalities (43)). If equalities (6) hold instead, then we have: 
We can then adopt the same reasoning following equalities (43) above to show that equalities (46) imply
ðt + 1Þ when equalities (A) hold.
We have just shown that the (weak) NDE assumption (i.e., equalities (3), (5), or (6)) implies: (1) and (2)), the right-hand sides of the previous equalities can be modified as follows under the NDE assumption (3): 
By definition of the counterfactuals in Section 4.3, we also have:
By transitivity, the last two equalities imply:
By expanding the parent notation and then making use of the equalities (64), (66), (A.3), and (A.4), the second of equalities (65) becomes By definition of the counterfactuals in Section 4.3, we also have:
By expanding the parent notation and then making use of equalities (64), (66), (67), (A.3), and (A.4), the third of equalities (65) becomes By definition of the counterfactuals in Section 4.3, we also have:
, U I0ð1Þ Þ.
.
We have just shown that the NDE assumption (3) implies equality (A.1) holds. We note that the proof of this result also holds under the weak NDE assumption if equalities (5) hold (because equalities (5) imply equalities (65)). If equalities (6) hold instead, then we have:
We can then adopt the same reasoning following equalities (65) above to show that equalities (68) imply equality (A.1) holds. We have thus shown that the (weak) NDE assumption (i.e., equalities (3), (5), or (6)) implies equality (A.1). This completes the proof of the proposition that, equalities (A) hold at t = 1 when the (weak) NDE assumption holds. By induction, the previous two propositions imply equalities (9) and (10) 
where EðjÞ denotes the following equality: In the proof below, we use bold font to indicate how each new equality is modified from its previous expression and we also indicate the assumption(s) supporting a new expression above the equal sign. We have for any j = t − 2, . . . , 0 The last equality corresponds to equality (B).
Thus, we have just shown EðjÞ ) Eðj − 1Þ. Above, we have shown the proposition that, for any j = t − 2 . . . , 0, if equality (A) holds then it implies equality (B) when the conditional independences (69), (70), and (71) hold. We now show the proposition that equality (A) holds at j = t − 2 when the conditional independences (69), (70), and (71) hold: , u ðn * ðt − 1ÞÞ, , u ðn * ðt − 1ÞÞ 
, u ða , u ðn * ðt − 1ÞÞ .
The last equality corresponds to equality (A) at j = t − 2. We have just shown the proposition that equality (A) holds at j = t − 2 when the conditional independences (69), (70), and (71) hold. By induction, the previous two propositions imply that equality (73) holds when the conditional independences (69), (70), and (71) hold (because P 0 Y * ð0Þ is nil). We note that the third equality above indeed holds under the conditional independence assumption (74) because, when the conditional probability ψ is defined, the sets f Above, we have shown the proposition that, for any j = t − 2, . . . , 0, if equality (C) holds then it implies equality (D) when the conditional independence (74) holds. We now show the proposition that equality (C) holds at j = t − 2 when the conditional independences (69), (70), (71), and (74) hold: The last equality corresponds to equality (C) at j = t − 2. We have just shown the proposition that equality (C) holds at j = t − 2.
-if by convention (the previous conditional probability is then undefined). We note again that this choice of convention has no impact on the definition of PðX d x , g = xÞ.
-if Q K + 1 j = 0 Q j yðjÞ, zðjÞ, i 0 ðjÞ j p 
From now on, to simplify notation, we drop the subscript t from the terms g t and Q t defined above. Thus, each reference to the functions g and Q below is an implicit reference to one of the functions g t and Q t above and we rely on the names of the function arguments to indicate to the reader which function g t and Q t is actually referenced. Using this new notation, we note that each factor g above for t = 0, . . . , K can be further factorized as follows when it is defined based on the conditional probability (i.e., if Q t j = 0 Q yðjÞ, zðjÞ, i 0 ðjÞ j p by convention (the previous conditional probability is then undefined).
-if g a 2 ðtÞ j p 
